Purkinje cell-specific males absent on the first (mMof) gene deletion results in an ataxia-telangiectasia-like neurological phenotype and backward walking in mice
- Departments of aRadiation Oncology,
- cNeurology,
- dCell Biology, and
- fPathology, University of Texas Southwestern Medical Center, Dallas, TX 75390;
- bDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108; and
- eInstitute for Cancer Genetics, Columbia University, New York, NY 10032
See allHide authors and affiliations
Edited* by Stephen P. Goff, Columbia University College of Physicians and Surgeons, New York, NY, and approved January 21, 2011 (received for review November 4, 2010)

Abstract
The brains of ataxia telangiectasia (AT) patients display an aberrant loss of Purkinje cells (PCs) that is postulated to contribute to the observed deficits in motor coordination as well as in learning and cognitive function. AT patients have mutations in the ataxia telangiectasia mutated (ATM) gene [Savitsky et al. (1995) Science 268:1749–1753]. However, in Atm-deficient mice, the neurological defects are limited, and the PCs are not deformed or lost as observed in AT patients [Barlow et al. (1996) Cell 86:159–171]. Here we report that PC-specific deletion of the mouse males absent on the first (mMof) gene (Cre−), which encodes a protein that specifically acetylates histone H4 at lysine 16 (H4K16ac) and influences ATM function, is critical for PC longevity. Mice deficient for PC-specific Mof display impaired motor coordination, ataxia, a backward-walking phenotype, and a reduced life span. Treatment of MofF/F/Pcp2-Cre+ mice with histone deacetylase inhibitors modestly prolongs PC survival and delays death. Therefore, Mof expression and H4K16 acetylation are essential for PC survival and function, and their absence leads to PC loss and cerebellar dysfunction similar to that observed in AT patients.
Footnotes
- 1To whom correspondence should be addressed. E-mail: tej.pandita{at}utsouthwestern.edu.
Author contributions: R.K., R.B., T.L., D.K.B., and T.K.P. designed research; R.K., A.G., S.N., R.K.P., and T.L. performed research; T.L. and D.K.B. contributed new reagents/analytic tools; R.K., C.R.H., J.W.S., R.B., D.K.B., and T.K.P. analyzed data; and C.R.H., J.W.S., D.K.B., and T.K.P. wrote the paper.
The authors declare no conflict of interest.
↵*This Direct Submission article had a prearranged editor.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1016524108/-/DCSupplemental.














